Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Nektar Therapeutics (NKTR)

-NasdaqGS
12.58 Up 0.29(2.36%) Jul 11, 3:59PM EDT
Prev Close:12.29
Open:12.26
Bid:N/A
Ask:12.58 x 100
1y Target Est:16.25
Beta:1.48
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:12.00 - 12.80
52wk Range:8.87 - 15.34
Volume:774,829
Avg Vol (3m):1,131,390
Market Cap:1.60B
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NKTRUp 2.36%1.60B
BMYUp 0.23%80.57B
ENZNUp 3.81%48.06M
GSKDown 1.27%129.28B

Key Statistics

Forward P/E (1 yr):419.33
P/S (ttm):10.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Jun-14) :-0.37
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback